Nutritional supplements and extracts like Olive have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Olive supplement and why should not take them?
Is it okay to take Olive extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.
A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.
To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.
Taking Olive extracts or nutritional supplements may benefit Primary Serous Cystadenoma of the Pancreas patients on Radiation treatment over Arugula nutritional supplements. But Olive supplements or Olive extracts offer less benefit if on Imatinib treatment for Primary Dermatofibrosarcoma Protuberans compared to Hesperidin. Similarly, taking nutritional supplements Olive may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene MLH1 over Persimmon. But avoid nutritional supplements Olive when at genetic risk of cancer due to mutation of gene POLH.
The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Olive beneficial and should not be taken? Why should Olive be not taken? Who should not take Olive? What are side effects of Olive with Imatinib chemotherapy? What are the benefits of Olive for cancer? Can Olive help fight cancer and so on.
Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.
Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.
These are some example questions which nutrition planning should help answer for you. Should you take supplements Olive? Should you take it when at genetic risk of cancer for mutation of gene MLH1? Should you take it when at genetic risk of cancer for mutation of gene POLH? Should you take it when diagnosed with Primary Dermatofibrosarcoma Protuberans? Should you take it when diagnosed with Primary Serous Cystadenoma of the Pancreas? Should you take it when on Radiation treatment? Should you continue taking it if you change your treatment from Radiation to Imatinib? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Olive extracts and nutritional supplements.
Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Serous Cystadenoma of the Pancreas or Primary Dermatofibrosarcoma Protuberans, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Olive.
So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Olive extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene MLH1 the same as due to mutation of gene POLH? Are the implications of Primary Serous Cystadenoma of the Pancreas the same as Primary Dermatofibrosarcoma Protuberans? Is it one and the same if you are on treatment with Imatinib or Radiation?
Olive – An Extract or Nutritional Supplement
Olives are drupes or stone fruits of an evergreen tree/shrub called Olea europaea or Olive Tree, native to Mediterranean Europe, Asia, and Africa. Olive oil is extracted from the liquid fat of the olives. Olive oil is usually used as a part of a healthy Mediterranean diet. Olives are packed with antioxidants and have many health benefits. Olives are rich in healthy fats and low in carbohydrates. Following are some of the potential health benefits of olives:
- May help prevent the loss of bone mass (Olga García-Martínez et al, Int J Food Sci Nutr., 2014)
- May help reduce blood pressure (Anwarul Hassan Gilani et al, Int J Food Sci Nutr., 2005)
- May help regulate cholesterol levels (M Aviram and Eias, Ann Nutr Metab., 1993)
However, avoid very high intake of olives as they contain small amounts of heavy metals and can result in many side effects.
Olive supplements contain many active ingredients including Palmitic Acid, L-histidine, L-phenylalanine, Acteoside and Quercetin 3-rutinoside at different concentration levels. The molecular pathways which are regulated by Olive include Focal Adhesion, Growth Factor Signaling, Apoptosis and Chromatin Remodeling. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Olive individually or in combination is an important decision to be made. When making decisions on the use of supplement Olive over other nutritional supplements – do consider all these factors.
Who Should not take Olive Supplements and Why?
There is no easy way to answer the question “For which cancers should I not chooseOlive nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Olive in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Olive should be avoided or not and why.
1. Will Olive Supplements benefit Primary Dermatofibrosarcoma Protuberans patients undergoing Imatinib treatment?
Primary Dermatofibrosarcoma Protuberans is characterized and driven by specific genetic mutations like FGFR1, KDM5A and MED12 leading to biochemical pathway changes in Growth Factor Signaling, Angiogenesis, MAPK Signaling, Oncogenic Histone Methylation and TGFB Signaling. A cancer treatment like Imatinib works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Olive supplement should not be taken for Primary Dermatofibrosarcoma Protuberans along with treatment Imatinib. Olive supplement impacts the biochemical pathway called Growth Factor Signaling which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any
2. Will Olive Supplements benefit Primary Serous Cystadenoma of the Pancreas Patients undergoing Radiation Treatment?
Primary Serous Cystadenoma of the Pancreas is characterized and driven by specific genetic mutations like TBC1D3F, ADAMTS19 and SERPINA3 leading to biochemical pathway changes in Focal Adhesion. A cancer treatment like Radiation works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Olive supplements should be considered for Primary Serous Cystadenoma of the Pancreas along with the treatment Radiation. Olive supplement impacts pathways/processes like Focal Adhesion which either obstruct drivers of Primary Serous Cystadenoma of the Pancreas and/or improve Radiation treatment effect.
Foods to Eat After Cancer Diagnosis!
No two cancers are the same. Go beyond the common nutrition guidelines for everyone and make personalized decisions about food and supplements with confidence.
3. What about Olive Supplements for Healthy Individuals with POLH Mutation associated Genetic Risk?
Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives. POLH is one of the genes generally available in panels for cancer risk testing.
POLH mutation causes biochemical pathways/processes like Apoptosis and DNA Repair to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Olive should not be taken when the genetic panel identifies mutation of POLH for Skin Cancer. Olive impacts pathways/processes like Apoptosis and creates adverse conditions with POLH.
4. What about Olive Supplements for Healthy Individuals with MLH1 Mutation associated Genetic Risk?
MLH1 is one of the genes available in panels for cancer risk testing. MLH1 mutation causes biochemical pathways/processes like Chromatin Remodeling and Mismatch Repair to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Olive supplements may be considered when the genetic panel identifies mutations in MLH1 for Colon Cancer. Olive impacts pathways/processes like Chromatin Remodeling and creates a canceling effect in those individuals with MLH1 mutation.
* Other Factors are also included like BMI, Treatments, Lifestyle Habits
It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Olive are chosen by you and can influence outcomes.
“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.
The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.
What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.
The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.
Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.
- cBioPortal for Cancer Genomics
- Verbascoside: Identification, Quantification, and Potential Sensitization of Colorectal Cancer Cells to 5-FU by Targeting PI3K/AKT Pathway.
- beta1 integrin targeting to enhance radiation therapy.
- Phenylethanoid glycosides from Digitalis purpurea and Penstemon linarioides with PKCalpha-inhibitory activity.
- Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
- cBioPortal for Cancer Genomics
Personalized Nutrition for Cancer!
Cancer changes with time. Customize and modify your nutrition based on cancer indication, treatments, lifestyle, food preferences, allergies and other factors.